References
- Broomé U, Olsson R, Lööf L, Bodemar G, Hultcrantz R, Danielsson Å, et al. Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut 1996; 38: 610–5
- Schrumpf E, Abdelnoor M, Fausa O, et al. Risk factors in primary sclerosing cholangitis. J Hepatol 1994; 21: 1061
- Escorsell A, Pares A, Rhodes J, et al. Epidemiology of primary sclerosing cholangitis in Spain. J Hepatol 1994; 21: 787–??
- Takikawa H, Takamori Y, Tanaka A, Kurihara H, Nakanuma Y. Analysis of 388 cases of primary sclerosing cholangitis in Japan; presence of a subgroup without pancreatic involvement in older patients. Hepatol Res 2004; 29: 153–9
- Lundqvist K, Broomé U. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis. Dis Colon Rectum 1997; 40: 541–6
- Moayyeri A, Daryani N, Bahrami H, Haghpanah B, Nayyer-Habibi A, Sadatsafavi M. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis. J Gastroenterol Hepatol 2005; 20: 366–70
- Textor H, Flacke S, Pauleit D, Keller E, Neubrand M, Terjung B, et al. Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography. Endoscopy 2002; 34: 984–90
- Vitellas K, El-Dieb A, Vaswani K, Bennett W, Fromkes J, Ellison C, et al. Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients. Am J Roentgenol. 2002; 179: 409–16
- Berstad A, Aabakken L, Smith H, Boberg K, Schrumpf E. Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2006; 4: 514–20
- Okolicsanyi L, Fabris L, Viaggi S, et al. Clinical presentation, natural history and prognostic variables: An Italian multi-center study. Eur J Gastroenterol 1996; 8: 685–??
- Wiesner R, Grambsch P, Dickson E, Ludwig J, MacCarty R, Hunter E, et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989; 10: 430–6
- Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Lööf L, Danielsson, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 2002; 36: 321–7
- Talwalkar J, Lindor K. Natural history and prognostic models in primary sclerosing cholangitis. Best Pract Res Clin Gastroenterol 2001; 15: 563–75
- Broomé U, Glaumann H, Lindström E, Lööf L, Almer A, Prytz H, et al. Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC). J Hepatol 2002; 36: 586–9
- Evans J, Acheson E. An epidemiological study of ulcerative colitis and regional enteritis in the Oxford Area. Gut 1965; 6: 311–24
- Grant A, Lalor P, Salmi M, Jalkanen S, Adams D. Homing of mucosal lumphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet 2002; 359: 150–7
- Loftus E, Sandborn W, Tremaine W, Mahoney D, Zinmeister A, Offord K, et al. Primary sclerosing cholangitis is associated with nonsmoking; a case control study. Gastroenterology 1996; 110: 1496–502
- Van Erpecum K, Smits S, Van de Meeberg P, Linn F, Wolfhagen F, vanBerge-Henegouwen G, et al. Risk of primary sclerosing cholangitis is associated with nonsmoking behaviour. Gastoenterology 1996; 110: 1503–6
- Olsson R, Broome U, Danielsson A, Hagerstrand I, Jarnerot G, Loof L, et al. Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features. Hepatogastroenterology 1999; 46: 136–41
- Lucey M, Neuberger J, Williams R. Primary biliary cirrhosis in men. Gut 1986; 27: 1373–6
- Gossard A, Angulo P, Lindor K. Secondary sclerosing cholangitis: a comparison to primary sclerosing cholangitis. Am J Gastroenterol 2005; 100: 1330–3
- Bambha K KW, Talwalkar J, Torgerson H, Benson JT, Therneau TM, Loftus EV, Jr, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364–9